Orforglipron (Oral) is a weight management research compound currently in stock directly from a verified Chinese manufacturer. Every batch is tested by the manufacturer for purity and concentration as part of routine quality control. Sourcing is direct — no intermediaries. Public catalog minimum is $300 in goods per supplier. Eligible new customers may use one first-order trial without a monetary minimum; 5% off goods applies from $3,500 per supplier, excluding shipping. International shipping available.
Orforglipron is an investigational nonpeptide small-molecule agonist of the glucagon-like peptide-1 receptor (GLP-1R). Unlike peptide GLP-1 receptor agonists, its small-molecule structure is being studied for oral administration without peptide-based delivery technology. Clinical research examines glucose-dependent insulin signaling, appetite regulation, gastric emptying, body weight, and related metabolic parameters.
| Name | Strength | Pack Size | Purity | Availability | Price (USD) |
|---|---|---|---|---|---|
| Orforglipron (Oral) | 6 mg/tablet | 100 tablets | — | Out of Stock | $173.00 |
| Orforglipron (Oral) | 6 mg/tablet | 100 tablets | — | In Stock | $195.00 |
| Orforglipron (Oral) | 12 mg/tablet | 100 tablets | — | Out of Stock | $293.00 |
| Orforglipron (Oral) | 12 mg/tablet | 100 tablets | — | In Stock | $315.00 |
For laboratory research use only. Not for human or veterinary use. PeptidesFromChina.co is a B2B wholesale supplier operating under strict research-use-only terms. All products are sold exclusively for in vitro and preclinical research purposes.